Molecular Biology

T.J. Schall, M. Lewis, K.J. Koller, A. Lee, G.C. Rice, G.H.W. Wong, T. Gatanoga, et al., "Molecular cloning and expression of a receptor for human tumor necrosis factor," Cell, 61:361-70, 1990. Thomas Schall (Genentech Inc., South San Francisco, Calif.): "The biological effects of the protein known as tumor necrosis factor (TNF) have puzzled inves- tigators for years. Though binding studies have revealed that virtually all mammalian cells possess TNF receptors, the molecule's biological activit

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

T.J. Schall, M. Lewis, K.J. Koller, A. Lee, G.C. Rice, G.H.W. Wong, T. Gatanoga, et al., "Molecular cloning and expression of a receptor for human tumor necrosis factor," Cell, 61:361-70, 1990.

Thomas Schall (Genentech Inc., South San Francisco, Calif.): "The biological effects of the protein known as tumor necrosis factor (TNF) have puzzled inves- tigators for years. Though binding studies have revealed that virtually all mammalian cells possess TNF receptors, the molecule's biological activities are somewhat paradoxical. On some cells, TNF acts as a growth factor, while on other cells--including certain tumor cells--it elicits clear cytotoxic effects.

"Our report on the molecular cloning and characterization of a cell-surface TNF receptor, along with a concomitant report by Hansruedi Loetscher and colleagues at Hoffmann-La Roche Ltd. (Cell, 61:351-59, 1990 [Hot Papers, The Scientist, Nov. 25, 1991, page 16]), for the first time allowed for an investigation of the complexities of TNF action ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies